Micronutrient-Fortified Complementary Feeding and Growth Outcomes in Infants Aged Six to Twelve Months: A Randomized Controlled Trial

Kubik Z¹, Wagner U², Kovacic M³

Introduction

The period from six to twelve months of age is a critical window for linear and ponderal growth, coinciding with the introduction of complementary foods alongside continued breastfeeding [2]. In many low- and middle-income settings, complementary foods are often nutritionally inadequate — low in iron, zinc, and other micronutrients — contributing to the steep rise in stunting prevalence that typically begins around six months and plateaus by roughly twenty-four months of age [3]. A landmark costing synthesis identified micronutrient-fortified complementary feeding among the highest-priority, cost-effective nutrition-specific interventions for reducing stunting and mortality at scale [4], while a companion review found that combining maternal nutrition education with direct provision of complementary foods produced larger growth benefits than education alone [5]. Because breast milk alone cannot meet infants' iron and other micronutrient requirements beyond roughly six months, and because plant-based complementary foods common in resource-limited settings have low micronutrient bioavailability, point-of-use fortification strategies have been developed to close this gap without requiring changes to household food preparation [6,7].

Two broad categories of fortified complementary feeding products dominate the literature. Multiple micronutrient powders (MNP), exemplified by the "Sprinkles" formulation, are single-dose sachets of encapsulated vitamins and minerals — centrally iron, but typically also zinc, vitamin A, and folic acid — sprinkled onto any semi-solid home-prepared food before consumption [8]. Small-quantity lipid-based nutrient supplements (SQ-LNS) are energy-dense, micronutrient-fortified pastes, typically peanut- or soy-based, providing roughly 100-120 kcal/day alongside an expanded micronutrient profile plus protein and essential fatty acids [9]. A third, less standardised category comprises fortified blended flours, cereals, and other complementary food vehicles evaluated in national fortification programmes, reviewed in detail for Vietnam and other Asian settings [10,11,12].

These approaches differ substantially in energy contribution, cost, and delivery logistics, and trials evaluating them use heterogeneous designs, comparators, and outcome definitions. This heterogeneity has produced a mixed evidence picture: some meta-analyses report clear, if modest, SQ-LNS benefits for linear growth and stunting prevention, while MNP trials more consistently demonstrate haematological benefit with less consistent growth effects [1,13]. This narrative review synthesises the published literature on micronutrient-fortified complementary feeding and growth outcomes in infants aged approximately six to twelve months, addressing: (1) what growth effects each approach produces; (2) how consistent these effects are across settings; and (3) what mechanisms and programmatic considerations should guide recommendations.

Methods

This is a narrative review of published randomised trials, systematic reviews and meta-analyses, and mechanistic studies identified through PubMed, Cochrane Library, and Europe PMC using combinations of the terms "micronutrient powder," "Sprinkles," "lipid-based nutrient supplement," "fortified complementary food," "infant growth," "stunting," "wasting," and "randomized controlled trial." Priority was given to randomised or cluster-randomised trials and individual participant data meta-analyses reporting anthropometric outcomes (length-for-age, weight-for-age, weight-for-length, mid-upper-arm circumference, stunting, wasting) in infants and young children in the approximate six-to-twenty-three-month range, since trials restricted solely to six-to-twelve months are few and most large efficacy trials enrol infants at six months and follow them through eighteen to twenty-four months. Findings are synthesised narratively rather than pooled quantitatively, reflecting heterogeneity in products, doses, comparators, and outcome measures.

Micronutrient Powders and Growth Outcomes

MNP efficacy has been most rigorously characterised for haematological outcomes: a Cochrane review of home fortification with MNP in children under two years found meaningful reductions in anaemia and iron deficiency compared with no intervention or placebo, alongside modest improvements in some studies' diarrhoea rates [14,8]. Growth effects, by contrast, have been inconsistent. A large-scale effectiveness trial of MNP distributed through the Integrated Child Development Services platform in Bihar, India, among children aged six to eighteen months demonstrated reduced anaemia and diarrhoea prevalence but no commensurate improvement in linear growth, consistent with the pattern across most MNP anthropometric endpoints [15]. Cluster-randomised "Sprinkles" trials in Western Kenya and elsewhere similarly demonstrated strong reductions in anaemia, iron deficiency, and vitamin A deficiency, again with growth as a secondary or unreported outcome [16]. A comprehensive systematic review and meta-analysis of micronutrient-fortified complementary foods in infants aged six to twenty-three months found that MNP improved haemoglobin and reduced anaemia and iron deficiency with high certainty, but that effects on length-for-age and weight-for-age z-scores were of low to very low certainty and generally null (Figure 1; Table 1) [1]. Broader reviews of micronutrient supplementation across under-five populations reach a similar conclusion: benefits cluster around micronutrient status and morbidity rather than growth, with modest weight gain but little consistent effect on linear growth [13,11].

Lipid-Based Nutrient Supplements and Growth Outcomes

SQ-LNS trials present a more consistent, if still modest, growth signal. Individual participant data meta-analyses pooling fourteen randomised controlled trials across multiple countries — encompassing more than 37,000 children — found that preventive SQ-LNS provision reduced the prevalence of stunting by approximately 12%, wasting by approximately 14%, low mid-upper-arm circumference by roughly 18%, and underweight by a comparable margin relative to control arms, with larger relative effects on severe stunting and severe wasting [9,17]. Effect modification analyses within this pooled dataset found benefits were generally larger in populations with higher baseline stunting or wasting prevalence, in children starting supplementation earlier, and with longer supplementation duration, without strong evidence that dose or formulation altered the direction of effect (Figure 2; Table 2) [18]. Individual efficacy trials illustrate this pattern: SQ-LNS provided to Ghanaian infants from six to eighteen months, alongside maternal supplementation, increased mean attained length at eighteen months relative to a maternal-only comparator, while parallel Malawi trials produced smaller or null aggregate growth effects, illustrating cross-country heterogeneity within the same iLiNS programme [19,20,21]. In Burkina Faso, SQ-LNS with concurrent malaria and diarrhoea treatment increased infant development scores and reduced stunting and wasting prevalence regardless of supplement zinc content, suggesting the energy and multi-micronutrient matrix itself drives much of the benefit [22,23]. Within the six-to-twelve-month window central to this review, a randomised trial in South Africa found SQ-LNS improved linear growth and psychomotor development scores and reduced iron deficiency anaemia without increasing infectious morbidity [24].

Figure 2: Representative relative risk reductions in stunting, wasting,

underweight, and low mid-upper-arm circumference from the pooled individual participant data meta-analysis of small-quantity lipid-based nutrient supplement trials [9,17].

Fortified Complementary Foods and Comparative Evidence

Beyond MNP and SQ-LNS, fortified blended flours, infant cereals, and centrally processed complementary food vehicles constitute a third category evaluated largely through national fortification programmes rather than individual efficacy trials. A systematic review of large-scale fortification programmes across multiple micronutrients and food vehicles found consistent improvements in biochemical micronutrient status, most robustly for iodine and folate, with more variable anthropometric evidence, reflecting the programmatic rather than trial-based design of this literature [11]. A cost-effectiveness analysis of subsidised fortified complementary foods in Pakistan suggests fortification can be a relatively low-cost means of narrowing micronutrient gaps at population scale, even where individual-level growth effects are modest [12]. A meta-analysis of fortified milk products found small but significant improvements in height and weight gain versus unfortified milk, reinforcing that an energy-and-micronutrient-dense matrix, delivered consistently, can shift growth trajectories even when the micronutrient premix alone would not [25]. Nutrient-dense whole foods can achieve a similar effect without industrial fortification: a trial providing a daily egg to infants from six months significantly increased lengthand weight-for-age versus no-egg controls, underscoring that the energy-, protein-, and micronutrient-density principle extends beyond manufactured fortificants [26]. The Cochrane review of preventive lipid-based nutrient supplements, pooling trials across six-to-twenty-three months, found moderate-certainty evidence that SQ-LNS modestly increases length and weight gain and reduces stunting, wasting, and anaemia odds relative to no intervention or corn-soy blend comparators, while comparisons against MNP specifically remained less conclusive [27]. This comparative literature situates SQ-LNS as the most consistently growth-promoting strategy currently supported by randomised evidence, with MNP and fortified processed foods offering complementary, largely status-focused benefits.

Mechanisms, Safety, and Programmatic Considerations

Several mechanisms plausibly explain the differential effects of SQ-LNS and MNP. SQ-LNS supply approximately 100-120 kcal/day alongside essential fatty acids and protein, directly addressing energy and macronutrient gaps that pure micronutrient powders — which contribute negligible energy — cannot [9]. This added energy and fat may also improve bioavailability of fat-soluble micronutrients such as vitamin A. Programmatically, SQ-LNS are costlier to produce and distribute than single-sachet MNP, and their higher energy density raises theoretical concerns about breast milk displacement or later overweight risk, though trial evidence has not demonstrated clinically significant displacement at recommended doses [18]. MNP, being cheaper and easier to distribute through existing child health platforms, remain attractive where anaemia and iron deficiency are the primary targets, as reflected in large national MNP distribution programmes [15,8]. Adherence also differs: powders mixed into a meal are logistically simple but depend on caregiver behaviour and adequate food quantity, whereas LNS pastes are consumed directly and provide a fixed nutrient dose. Safety monitoring across both product classes has generally found low adverse-event rates, though iron-containing formulations warrant continued morbidity surveillance in malaria-endemic settings [14]. The evidence suggests intervention choice should be tailored to the dominant local nutritional problem — anaemia versus growth faltering — and to delivery capacity, rather than treated as a uniform category.

Study Population Comparator Duration Key Growth Finding

Hess et al. Young Corn-soy 9 months Reduced [22] children, blend stunting and Burkina wasting Faso prevalence Das et al. Children No intervent Systematic Moderate-ce [27] 6-23 months ion/corn-so review rtainty (Cochrane) y blend increase in length and weight gain

Conclusion

Across a substantial body of randomised and meta-analytic evidence, micronutrient-fortified complementary feeding strategies produce meaningfully different growth outcomes depending on formulation. Small-quantity lipid-based nutrient supplements consistently, if modestly, reduce stunting, wasting, and low mid-upper-arm circumference across diverse settings, including within the six-to-twelve-month window central to this review, most plausibly through their combined energy, fat, and micronutrient contribution rather than micronutrient content alone. Multiple micronutrient powders reliably improve iron status and reduce anaemia but show weaker, less consistent effects on growth. Fortified complementary food vehicles delivered through national programmes occupy an intermediate position, offering population-scale micronutrient improvements at comparatively low cost. Clinically, SQ-LNS should be prioritised where growth faltering and wasting are prevalent, while MNP remain an efficient, lower-cost option where anaemia control is the primary objective; further trials restricted specifically to six-to-twelve months, with harmonised outcome definitions, would help resolve remaining uncertainty about optimal formulation, dose, and duration.

References

1. Csölle I, Felső R, Szabó É, Metzendorf MI, Schwingshackl L, Ferenci T, Lohner S. Health outcomes associated with micronutrient-fortified complementary foods in infants and young children aged 6-23 months: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2022;6(8):533-544. doi:10.1016/S2352-4642(22)00147-X.
2. Dewey KG, Adu-Afarwuah S. Systematic review of the efficacy and effectiveness of complementary feeding interventions in developing countries. Matern Child Nutr. 2008;4(Suppl
3. :24-85. doi:10.1111/j.1740-8709.2007.00124.x.
4. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, Ezzati M, Grantham-McGregor S, Katz J, Martorell R, Uauy R. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet. 2013;382(9890):427-451. doi:10.1016/S0140-6736(13)60937-X. PMID:23746772.
5. Bhutta ZA, Das JK, Rizvi A, Gaffey MF, Walker N, Horton S, Webb P, Lartey A, Black RE. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet. 2013;382(9890):452-477. doi:10.1016/S0140-6736(13)60996-4.
6. Salam RA, Das JK, Lassi ZS, Bhutta ZA. Impact of maternal education about complementary feeding and provision of complementary foods on child growth in developing countries. BMC Public Health. 2013;13(Suppl 3):S13. doi:10.1186/1471-2458-13-S3-S13. PMID:24564534.
7. Nestel P, Briend A, de Benoist B, Decker E, Ferguson E, Fontaine O, Micardi A, Nalubola R. Complementary food supplements to achieve micronutrient adequacy for infants and young children. J Pediatr Gastroenterol Nutr. 2003;36(3):316-328. doi:10.1002/j.1536-4801.2003.tb08019.x.
8. Gibson RS, Carriquiry A, Gibbs MM. Selecting desirable micronutrient fortificants for plant-based complementary foods for infants and young children in low-income countries. J Sci Food Agric. 2015;95(2):221-224. doi:10.1002/jsfa.6701.
9. Suchdev PS, Jefferds MED, Ota E, da Silva Lopes K, De-Regil LM. Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age. Cochrane Database Syst Rev. 2020;2(2):CD008959. doi:10.1002/14651858.CD008959.pub3.
10. Dewey KG, Stewart CP, Wessells KR, Prado EL, Arnold CD. Small-quantity lipid-based nutrient supplements for the prevention of child malnutrition and promotion of healthy development: overview of individual participant data meta-analysis and programmatic implications. Am J Clin Nutr. 2021;114(Suppl 1):3S-14S. doi:10.1093/ajcn/nqab279.
11. Berger J, Wieringa FT, Laillou A, Pham Van P, Dijkhuizen MA. Strategies to improve micronutrient status of infants and young children with special attention to complementary foods fortified with micronutrients: perspectives from Vietnam. In: Handbook of Food Fortification and Health. New York: Springer; 2013:335-346. doi:10.1007/978-1-4614-7110-3_26.
12. Keats EC, Neufeld LM, Garrett GS, Mbuya MNN, Bhutta ZA. Improved micronutrient status and health outcomes in lowand middle-income countries following large-scale fortification: evidence from a systematic review and meta-analysis. Am J Clin Nutr. 2019;109(6):1696-1708. doi:10.1093/ajcn/nqz023. PMID:30997493.
13. Wieser S, Brunner B, Tzogiou C, Plessow R, Zimmermann MB, Farebrother J, Soofi S, Bhatti Z, Ahmed I, Bhutta ZA. Reducing micronutrient deficiencies in Pakistani children: are subsidies on fortified complementary foods cost-effective? Public Health Nutr. 2018;21(15):2893-2906. doi:10.1017/S1368980018001660.
14. Tam E, Keats EC, Rind F, Das JK, Bhutta ZA. Micronutrient supplementation and fortification interventions on health and development outcomes among children under-five in low- and middle-income countries: a systematic review and meta-analysis. Nutrients. 2020;12(2):289. doi:10.3390/nu12020289. PMID:31973225.
15. De-Regil LM, Suchdev PS, Vist GE, Walleser S, Peña-Rosas JP. Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age (Review). Evid Based Child Health. 2013;8(1):112-201. doi:10.1002/ebch.1895. PMID:23878126.
16. Young MF, Mehta RV, Gosdin L, Kekre P, Verma P, Larson LM, Girard AW, Ramakrishnan U, Chaudhuri I, Srikantiah S, Martorell R. Home fortification of complementary foods reduces anemia and diarrhea among children aged 6-18 months in Bihar, India: a large-scale effectiveness trial. J Nutr. 2021;151(7):1983-1992. doi:10.1093/jn/nxab065.
17. Suchdev PS, Ruth LJ, Woodruff BA, Mbakaya C, Mandava U, Flores-Ayala R, Jefferds MED, Quick R. Selling Sprinkles micronutrient powder reduces anemia, iron deficiency, and vitamin A deficiency in young children in Western Kenya: a cluster-randomized controlled trial. Am J Clin Nutr. 2012;95(5):1223-1230. doi:10.3945/ajcn.111.030072.
18. Dewey KG, Arnold CD, Wessells KR, Prado EL, et al. Preventive small-quantity lipid-based nutrient supplements reduce severe wasting and severe stunting among young children: an individual participant data meta-analysis of randomized controlled trials. Am J Clin Nutr. 2022;116(5):1314-1333. doi:10.1093/ajcn/nqac232.
19. Dewey KG, Wessells KR, Arnold CD, Prado EL, Abbeddou S, Adu-Afarwuah S, et al., Stewart CP. Characteristics that modify the effect of small-quantity lipid-based nutrient supplementation on child growth: an individual participant data meta-analysis of randomized controlled trials. Am J Clin Nutr. 2021;114(Suppl 1):15S-42S. doi:10.1093/ajcn/nqab278. PMID:34590672.
20. Ashorn P, Alho L, Ashorn U, Cheung YB, Dewey KG, Gondwe A, Harjunmaa U, Lartey A, Phiri N, Phiri TE, Vosti SA, Zeilani M, Maleta K. Supplementation of maternal diets during pregnancy and for 6 months postpartum and infant diets thereafter with small-quantity lipid-based nutrient supplements does not promote child growth by 18 months of age in rural Malawi: a randomized controlled trial. J Nutr. 2015;145(6):1345-1353. doi:10.3945/jn.114.207225.
21. Maleta KM, Phuka J, Alho L, Cheung YB, Dewey KG, Ashorn U, Phiri N, Phiri TE, Vosti SA, Zeilani M, Kumwenda C, Bendabenda J, Pulakka A, Ashorn P. Provision of 10-40 g/d lipid-based nutrient supplements from 6 to 18 months of age does not prevent linear growth faltering in Malawi. J Nutr. 2015;145(8):1909-1915. doi:10.3945/jn.114.208181.
22. Prado EL, Maleta K, Ashorn P, Ashorn U, Vosti SA, Sadalaki J, Dewey KG. Effects of maternal and child lipid-based nutrient supplements on infant development: a randomized trial in Malawi. Am J Clin Nutr. 2016;103(3):784-793. doi:10.3945/ajcn.115.114579. PMID:26843155.
23. Hess SY, Abbeddou S, Jimenez EY, Somé JW, Vosti SA, Ouédraogo ZP, Guissou RM, Ouédraogo JB, Brown KH. Small-quantity lipid-based nutrient supplements, regardless of their zinc content, increase growth and reduce the prevalence of stunting and wasting in young Burkinabe children: a cluster-randomized trial. PLoS One. 2015;10(3):e0122242. doi:10.1371/journal.pone.0122242.
24. Prado EL, Abbeddou S, Yakes Jimenez E, Somé JW, Ouédraogo ZP, Vosti SA, Dewey KG, Brown KH, Hess SY, Ouédraogo JB. Lipid-based nutrient supplements plus malaria and diarrhea treatment increase infant development scores in a cluster-randomized trial in Burkina Faso. J Nutr. 2016;146(4):814-822. doi:10.3945/jn.115.225524.
25. Smuts CM, Matsungo TM, Malan L, Kruger HS, Rothman M, Kvalsvig JD, Covic N, Joosten K, Osendarp SJM, Bruins MJ, Frenken LGJ, Lombard CJ, Faber M. Effect of small-quantity lipid-based nutrient supplements on growth, psychomotor development, iron status, and morbidity among 6- to 12-mo-old infants in South Africa: a randomized controlled trial. Am J Clin Nutr. 2019;109(1):55-68. doi:10.1093/ajcn/nqy282. PMID:30649163.
26. Matsuyama M, Harb T, David M, Davies PSW, Hill RJ. Effect of fortified milk on growth and nutritional status in young children: a systematic review and meta-analysis. Public Health Nutr. 2017;20(7):1214-1225. doi:10.1017/S1368980016003189. PMID:27938461.
27. Iannotti LL, Lutter CK, Stewart CP, Gallegos Riofrío CA, Malo C, Reinhart G, Palacios A, Karp C, Chapnick M, Cox K, Waters WF. Eggs in early complementary feeding and child growth: a randomized controlled trial. Pediatrics. 2017;140(1):e20163459. doi:10.1542/peds.2016-3459.
28. Das JK, Salam RA, Weise Prinzo Z, Sadiq Sheikh S, Bhutta ZA. Provision of preventive lipid-based nutrient supplements given with complementary foods to infants and young children 6 to 23 months of age for health, nutrition, and developmental outcomes. Cochrane Database Syst Rev. 2019;2019(5):CD012611. doi:10.1002/14651858.CD012611.pub3.